Rose Merc [ROSEMER] vs Goldiam [GOLDIAM] Detailed Stock Comparison
Rose Merc
BSE
Loading...
Goldiam
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rose Merc wins in 16 metrics, Goldiam wins in 3 metrics, with 0 ties. Rose Merc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rose Merc | Goldiam | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.90 | 30.02 | Rose Merc |
| Price-to-Book Ratio | 0.57 | 5.22 | Rose Merc |
| Debt-to-Equity Ratio | 0.02 | 3.63 | Rose Merc |
| PEG Ratio | -0.06 | 0.57 | Rose Merc |
| EV/EBITDA | 2.45 | 21.14 | Rose Merc |
| Profit Margin (TTM) | 45.05% | 15.23% | Rose Merc |
| Operating Margin (TTM) | 21.15% | 17.23% | Rose Merc |
| EBITDA Margin (TTM) | 21.15% | 17.23% | Rose Merc |
| Return on Equity | 20.38% | 15.72% | Rose Merc |
| Return on Assets (TTM) | 18.55% | 13.10% | Rose Merc |
| Free Cash Flow (TTM) | $-31.22M | $-203.67M | Rose Merc |
| Dividend Yield | 0.21% | 0.55% | Goldiam |
| 1-Year Return | 65.46% | 55.30% | Rose Merc |
| Price-to-Sales Ratio (TTM) | 0.61 | 4.57 | Rose Merc |
| Enterprise Value | $412.48M | $36.09B | Goldiam |
| EV/Revenue Ratio | 0.52 | 4.27 | Rose Merc |
| Gross Profit Margin (TTM) | 46.32% | 30.78% | Rose Merc |
| Revenue per Share (TTM) | $142 | $79 | Rose Merc |
| Earnings per Share (Diluted) | $3.10 | $12.05 | Goldiam |
| Beta (Stock Volatility) | N/A | 0.97 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rose Merc vs Goldiam Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rose Merc | -1.97% | -9.52% | 17.15% | 74.18% | 18.57% | -18.43% |
| Goldiam | -0.64% | 0.04% | 7.49% | -1.55% | -6.35% | -5.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rose Merc | 65.46% | 65.46% | 65.46% | 65.46% | 65.46% | 65.46% |
| Goldiam | 55.30% | 157.23% | 1,436.96% | 3,790.32% | 547.23% | 475.20% |
Performance & Financial Health Analysis: Rose Merc vs Goldiam
| Metric | ROSEMER | GOLDIAM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹478.97M | ₹38.64B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 127 | 787,546 |
| 90 Day Avg. Volume | 14,969 | 537,787 |
| Last Close | ₹84.80 | ₹359.50 |
| 52 Week Range | ₹41.01 - ₹177.45 | ₹233.61 - ₹569.00 |
| % from 52W High | -52.21% | -36.82% |
| All-Time High | ₹114.51 (Jul 25, 2025) | ₹569.00 (Jan 13, 2025) |
| % from All-Time High | -25.95% | -36.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.70% | 0.39% |
| Quarterly Earnings Growth | N/A | 0.53% |
| Financial Health | ||
| Profit Margin (TTM) | 0.45% | 0.15% |
| Operating Margin (TTM) | 0.21% | 0.17% |
| Return on Equity (TTM) | 0.20% | 0.16% |
| Debt to Equity (MRQ) | 0.02 | 3.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹152.37 | ₹69.29 |
| Cash per Share (MRQ) | N/A | ₹26.60 |
| Operating Cash Flow (TTM) | ₹-68,186,000 | ₹55.58M |
| Levered Free Cash Flow (TTM) | ₹161.33M | ₹1.17B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.21% | 0.55% |
| Last 12-Month Dividend | ₹0.10 | ₹2.00 |
Valuation & Enterprise Metrics Analysis: Rose Merc vs Goldiam
| Metric | ROSEMER | GOLDIAM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.90 | 30.02 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.06 | 0.57 |
| Price to Sales (TTM) | 0.61 | 4.57 |
| Price to Book (MRQ) | 0.57 | 5.22 |
| Market Capitalization | ||
| Market Capitalization | ₹478.97M | ₹38.64B |
| Enterprise Value | ₹412.48M | ₹36.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.52 | 4.27 |
| Enterprise to EBITDA | 2.45 | 21.14 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.97 |
| Book Value per Share (MRQ) | ₹152.37 | ₹69.29 |
Financial Statements Comparison: Rose Merc vs Goldiam
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ROSEMER | GOLDIAM |
|---|---|---|
| Revenue/Sales | ₹221.29M | ₹1.99B |
| Cost of Goods Sold | ₹118.78M | ₹1.30B |
| Gross Profit | ₹102.51M | ₹689.93M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹66.53M | ₹345.17M |
| EBITDA | ₹67.15M | ₹395.27M |
| Pre-Tax Income | ₹63.09M | ₹375.88M |
| Income Tax | ₹605,000 | ₹144.10M |
| Net Income (Profit) | ₹62.48M | ₹231.78M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ROSEMER | GOLDIAM |
|---|---|---|
| Cash & Equivalents | ₹86.04M | ₹1.81B |
| Total Current Assets | ₹442.09M | ₹8.26B |
| Total Current Liabilities | ₹60.98M | ₹1.27B |
| Long-Term Debt | ₹16.86M | ₹144.13M |
| Total Shareholders Equity | ₹791.70M | ₹7.45B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹589.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ROSEMER | GOLDIAM |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ROSEMER | GOLDIAM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 127 | 787,546 |
| Average Daily Volume (90 Day) | 14,969 | 537,787 |
| Shares Outstanding | 5.53M | 106.80M |
| Float Shares | N/A | 36.76M |
| % Held by Insiders | 0.65% | 0.64% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Rose Merc vs Goldiam
| Metric | ROSEMER | GOLDIAM |
|---|---|---|
| Last 12-Month Dividend | ₹0.10 | ₹2.00 |
| Last 12-Month Dividend Yield | 0.21% | 0.55% |
| 3-Year Avg Annual Dividend | ₹0.03 | ₹1.93 |
| 3-Year Avg Dividend Yield | 0.19% | 0.62% |
| 3-Year Total Dividends | ₹0.10 | ₹5.80 |
| Ex-Dividend Date | Sep 23, 2024 | Feb 14, 2025 |